CN108018273B - Long-chain unsaturated fatty acid specific lipase mutant and application thereof - Google Patents
Long-chain unsaturated fatty acid specific lipase mutant and application thereof Download PDFInfo
- Publication number
- CN108018273B CN108018273B CN201810097101.3A CN201810097101A CN108018273B CN 108018273 B CN108018273 B CN 108018273B CN 201810097101 A CN201810097101 A CN 201810097101A CN 108018273 B CN108018273 B CN 108018273B
- Authority
- CN
- China
- Prior art keywords
- lipase
- mutant
- fatty acid
- thr
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090001060 Lipase Proteins 0.000 title claims abstract description 51
- 102000004882 Lipase Human genes 0.000 title claims abstract description 50
- 239000004367 Lipase Substances 0.000 title claims abstract description 49
- 235000019421 lipase Nutrition 0.000 title claims abstract description 49
- 235000021122 unsaturated fatty acids Nutrition 0.000 title abstract description 22
- 150000004670 unsaturated fatty acids Chemical class 0.000 title abstract description 22
- 239000003549 soybean oil Substances 0.000 claims abstract description 28
- 235000012424 soybean oil Nutrition 0.000 claims abstract description 28
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 6
- 239000008158 vegetable oil Substances 0.000 claims description 6
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 4
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 4
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 235000019484 Rapeseed oil Nutrition 0.000 claims description 3
- 230000036541 health Effects 0.000 claims description 3
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 claims description 3
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 3
- 239000013612 plasmid Substances 0.000 claims description 3
- 241000203069 Archaea Species 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 claims description 2
- 241000233866 Fungi Species 0.000 claims description 2
- 235000019483 Peanut oil Nutrition 0.000 claims description 2
- 235000019498 Walnut oil Nutrition 0.000 claims description 2
- 235000005687 corn oil Nutrition 0.000 claims description 2
- 239000002285 corn oil Substances 0.000 claims description 2
- 235000012343 cottonseed oil Nutrition 0.000 claims description 2
- 239000002385 cottonseed oil Substances 0.000 claims description 2
- 235000013305 food Nutrition 0.000 claims description 2
- 239000004006 olive oil Substances 0.000 claims description 2
- 235000008390 olive oil Nutrition 0.000 claims description 2
- 239000000312 peanut oil Substances 0.000 claims description 2
- 235000019871 vegetable fat Nutrition 0.000 claims description 2
- 239000008170 walnut oil Substances 0.000 claims description 2
- 241000196324 Embryophyta Species 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 239000003925 fat Substances 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 abstract description 74
- 108090000790 Enzymes Proteins 0.000 abstract description 74
- 230000007062 hydrolysis Effects 0.000 abstract description 33
- 238000006460 hydrolysis reaction Methods 0.000 abstract description 33
- 150000004665 fatty acids Chemical class 0.000 abstract description 16
- 235000014113 dietary fatty acids Nutrition 0.000 abstract description 15
- 229930195729 fatty acid Natural products 0.000 abstract description 15
- 239000000194 fatty acid Substances 0.000 abstract description 15
- 230000008859 change Effects 0.000 abstract description 3
- 230000035772 mutation Effects 0.000 abstract description 3
- 238000010353 genetic engineering Methods 0.000 abstract description 2
- 238000012916 structural analysis Methods 0.000 abstract description 2
- 241000235527 Rhizopus Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 40
- 239000000758 substrate Substances 0.000 description 13
- 230000003301 hydrolyzing effect Effects 0.000 description 10
- 150000004671 saturated fatty acids Chemical class 0.000 description 10
- 239000000243 solution Substances 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 7
- 241000235528 Rhizopus microsporus var. chinensis Species 0.000 description 6
- 235000019626 lipase activity Nutrition 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000003441 saturated fatty acids Nutrition 0.000 description 6
- 150000001413 amino acids Chemical group 0.000 description 5
- 150000004668 long chain fatty acids Chemical class 0.000 description 5
- 238000002741 site-directed mutagenesis Methods 0.000 description 5
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 4
- OEVCHROQUIVQFZ-YTLHQDLWSA-N Ala-Thr-Ala Chemical compound C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](C)C(O)=O OEVCHROQUIVQFZ-YTLHQDLWSA-N 0.000 description 4
- GUYHHBZCBQZLFW-GUBZILKMSA-N Lys-Gln-Cys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CS)C(=O)O)N GUYHHBZCBQZLFW-GUBZILKMSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- MLSKFHLRFVGNLL-WDCWCFNPSA-N Gln-Leu-Thr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MLSKFHLRFVGNLL-WDCWCFNPSA-N 0.000 description 3
- 108010048733 Lipozyme Proteins 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000006555 catalytic reaction Methods 0.000 description 3
- -1 fatty acid salts Chemical class 0.000 description 3
- 235000021588 free fatty acids Nutrition 0.000 description 3
- FCCDDURTIIUXBY-UHFFFAOYSA-N lipoamide Chemical compound NC(=O)CCCCC1CCSS1 FCCDDURTIIUXBY-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000007127 saponification reaction Methods 0.000 description 3
- LZRNYBIJOSKKRJ-XVYDVKMFSA-N Ala-Asp-His Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N LZRNYBIJOSKKRJ-XVYDVKMFSA-N 0.000 description 2
- IKKVASZHTMKJIR-ZKWXMUAHSA-N Ala-Asp-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O IKKVASZHTMKJIR-ZKWXMUAHSA-N 0.000 description 2
- FVSOUJZKYWEFOB-KBIXCLLPSA-N Ala-Gln-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)N FVSOUJZKYWEFOB-KBIXCLLPSA-N 0.000 description 2
- LXAARTARZJJCMB-CIQUZCHMSA-N Ala-Ile-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LXAARTARZJJCMB-CIQUZCHMSA-N 0.000 description 2
- 108010011667 Ala-Phe-Ala Proteins 0.000 description 2
- XRNXPIGJPQHCPC-RCWTZXSCSA-N Arg-Thr-Val Chemical compound CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(N)=N)[C@@H](C)O)C(O)=O XRNXPIGJPQHCPC-RCWTZXSCSA-N 0.000 description 2
- ZZXMOQIUIJJOKZ-ZLUOBGJFSA-N Asn-Asn-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(N)=O ZZXMOQIUIJJOKZ-ZLUOBGJFSA-N 0.000 description 2
- DJIMLSXHXKWADV-CIUDSAMLSA-N Asn-Leu-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(N)=O DJIMLSXHXKWADV-CIUDSAMLSA-N 0.000 description 2
- NPZJLGMWMDNQDD-GHCJXIJMSA-N Asn-Ser-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O NPZJLGMWMDNQDD-GHCJXIJMSA-N 0.000 description 2
- KYQNAIMCTRZLNP-QSFUFRPTSA-N Asp-Ile-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O KYQNAIMCTRZLNP-QSFUFRPTSA-N 0.000 description 2
- DJCAHYVLMSRBFR-QXEWZRGKSA-N Asp-Met-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CC(O)=O DJCAHYVLMSRBFR-QXEWZRGKSA-N 0.000 description 2
- KGHLGJAXYSVNJP-WHFBIAKZSA-N Asp-Ser-Gly Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O KGHLGJAXYSVNJP-WHFBIAKZSA-N 0.000 description 2
- GWWSUMLEWKQHLR-NUMRIWBASA-N Asp-Thr-Glu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)O)N)O GWWSUMLEWKQHLR-NUMRIWBASA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- DAAUVRPSZRDMBV-KBIXCLLPSA-N Gln-Ile-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCC(=O)N)N DAAUVRPSZRDMBV-KBIXCLLPSA-N 0.000 description 2
- CELXWPDNIGWCJN-WDCWCFNPSA-N Gln-Lys-Thr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CELXWPDNIGWCJN-WDCWCFNPSA-N 0.000 description 2
- SOEXCCGNHQBFPV-DLOVCJGASA-N Gln-Val-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(O)=O SOEXCCGNHQBFPV-DLOVCJGASA-N 0.000 description 2
- JBRBACJPBZNFMF-YUMQZZPRSA-N Gly-Ala-Lys Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN JBRBACJPBZNFMF-YUMQZZPRSA-N 0.000 description 2
- LPCKHUXOGVNZRS-YUMQZZPRSA-N Gly-His-Ser Chemical compound [H]NCC(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O LPCKHUXOGVNZRS-YUMQZZPRSA-N 0.000 description 2
- MHXKHKWHPNETGG-QWRGUYRKSA-N Gly-Lys-Leu Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O MHXKHKWHPNETGG-QWRGUYRKSA-N 0.000 description 2
- UWQDKRIZSROAKS-FJXKBIBVSA-N Gly-Met-Thr Chemical compound [H]NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O UWQDKRIZSROAKS-FJXKBIBVSA-N 0.000 description 2
- JPVGHHQGKPQYIL-KBPBESRZSA-N Gly-Phe-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 JPVGHHQGKPQYIL-KBPBESRZSA-N 0.000 description 2
- FKESCSGWBPUTPN-FOHZUACHSA-N Gly-Thr-Asn Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O FKESCSGWBPUTPN-FOHZUACHSA-N 0.000 description 2
- GWCJMBNBFYBQCV-XPUUQOCRSA-N Gly-Val-Ala Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O GWCJMBNBFYBQCV-XPUUQOCRSA-N 0.000 description 2
- SYOJVRNQCXYEOV-XVKPBYJWSA-N Gly-Val-Glu Chemical compound [H]NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SYOJVRNQCXYEOV-XVKPBYJWSA-N 0.000 description 2
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 2
- GJMHMDKCJPQJOI-IHRRRGAJSA-N His-Lys-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CN=CN1 GJMHMDKCJPQJOI-IHRRRGAJSA-N 0.000 description 2
- PNDMHTTXXPUQJH-RWRJDSDZSA-N Ile-Glu-Thr Chemical compound N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@H](O)C)C(=O)O PNDMHTTXXPUQJH-RWRJDSDZSA-N 0.000 description 2
- CIJLNXXMDUOFPH-HJWJTTGWSA-N Ile-Pro-Phe Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 CIJLNXXMDUOFPH-HJWJTTGWSA-N 0.000 description 2
- NGKPIPCGMLWHBX-WZLNRYEVSA-N Ile-Tyr-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N NGKPIPCGMLWHBX-WZLNRYEVSA-N 0.000 description 2
- WRDTXMBPHMBGIB-STECZYCISA-N Ile-Tyr-Val Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)CC1=CC=C(O)C=C1 WRDTXMBPHMBGIB-STECZYCISA-N 0.000 description 2
- APQYGMBHIVXFML-OSUNSFLBSA-N Ile-Val-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N APQYGMBHIVXFML-OSUNSFLBSA-N 0.000 description 2
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 2
- DLCOFDAHNMMQPP-SRVKXCTJSA-N Leu-Asp-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DLCOFDAHNMMQPP-SRVKXCTJSA-N 0.000 description 2
- VWHGTYCRDRBSFI-ZETCQYMHSA-N Leu-Gly-Gly Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)NCC(O)=O VWHGTYCRDRBSFI-ZETCQYMHSA-N 0.000 description 2
- WRLPVDVHNWSSCL-MELADBBJSA-N Leu-His-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@@H]2C(=O)O)N WRLPVDVHNWSSCL-MELADBBJSA-N 0.000 description 2
- ONPJGOIVICHWBW-BZSNNMDCSA-N Leu-Lys-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 ONPJGOIVICHWBW-BZSNNMDCSA-N 0.000 description 2
- ICYRCNICGBJLGM-HJGDQZAQSA-N Leu-Thr-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(O)=O ICYRCNICGBJLGM-HJGDQZAQSA-N 0.000 description 2
- NTBFKPBULZGXQL-KKUMJFAQSA-N Lys-Asp-Tyr Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NTBFKPBULZGXQL-KKUMJFAQSA-N 0.000 description 2
- LLSUNJYOSCOOEB-GUBZILKMSA-N Lys-Glu-Asp Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O LLSUNJYOSCOOEB-GUBZILKMSA-N 0.000 description 2
- DCRWPTBMWMGADO-AVGNSLFASA-N Lys-Glu-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DCRWPTBMWMGADO-AVGNSLFASA-N 0.000 description 2
- YCJCEMKOZOYBEF-OEAJRASXSA-N Lys-Thr-Phe Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O YCJCEMKOZOYBEF-OEAJRASXSA-N 0.000 description 2
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 2
- 108010084311 Novozyme 435 Proteins 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- NOFBJKKOPKJDCO-KKXDTOCCSA-N Phe-Ala-Tyr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O NOFBJKKOPKJDCO-KKXDTOCCSA-N 0.000 description 2
- JEGFCFLCRSJCMA-IHRRRGAJSA-N Phe-Arg-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(=O)O)N JEGFCFLCRSJCMA-IHRRRGAJSA-N 0.000 description 2
- WFHRXJOZEXUKLV-IRXDYDNUSA-N Phe-Gly-Tyr Chemical compound C([C@H](N)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 WFHRXJOZEXUKLV-IRXDYDNUSA-N 0.000 description 2
- DVOCGBNHAUHKHJ-DKIMLUQUSA-N Phe-Ile-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O DVOCGBNHAUHKHJ-DKIMLUQUSA-N 0.000 description 2
- ZLAKUZDMKVKFAI-JYJNAYRXSA-N Phe-Pro-Val Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O ZLAKUZDMKVKFAI-JYJNAYRXSA-N 0.000 description 2
- BPIMVBKDLSBKIJ-FCLVOEFKSA-N Phe-Thr-Phe Chemical compound C([C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 BPIMVBKDLSBKIJ-FCLVOEFKSA-N 0.000 description 2
- HFZNNDWPHBRNPV-KZVJFYERSA-N Pro-Ala-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O HFZNNDWPHBRNPV-KZVJFYERSA-N 0.000 description 2
- ORPZXBQTEHINPB-SRVKXCTJSA-N Pro-Arg-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1)C(O)=O ORPZXBQTEHINPB-SRVKXCTJSA-N 0.000 description 2
- KIPIKSXPPLABPN-CIUDSAMLSA-N Pro-Glu-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1 KIPIKSXPPLABPN-CIUDSAMLSA-N 0.000 description 2
- AFXCXDQNRXTSBD-FJXKBIBVSA-N Pro-Gly-Thr Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O AFXCXDQNRXTSBD-FJXKBIBVSA-N 0.000 description 2
- LPGSNRSLPHRNBW-AVGNSLFASA-N Pro-His-Val Chemical compound C([C@@H](C(=O)N[C@@H](C(C)C)C([O-])=O)NC(=O)[C@H]1[NH2+]CCC1)C1=CN=CN1 LPGSNRSLPHRNBW-AVGNSLFASA-N 0.000 description 2
- FYKUEXMZYFIZKA-DCAQKATOSA-N Pro-Pro-Gln Chemical compound [H]N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O FYKUEXMZYFIZKA-DCAQKATOSA-N 0.000 description 2
- DWPXHLIBFQLKLK-CYDGBPFRSA-N Pro-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 DWPXHLIBFQLKLK-CYDGBPFRSA-N 0.000 description 2
- MKGIILKDUGDRRO-FXQIFTODSA-N Pro-Ser-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1 MKGIILKDUGDRRO-FXQIFTODSA-N 0.000 description 2
- IIRBTQHFVNGPMQ-AVGNSLFASA-N Pro-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@@H]1CCCN1 IIRBTQHFVNGPMQ-AVGNSLFASA-N 0.000 description 2
- KNZQGAUEYZJUSQ-ZLUOBGJFSA-N Ser-Asp-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)N KNZQGAUEYZJUSQ-ZLUOBGJFSA-N 0.000 description 2
- NMZXJDSKEGFDLJ-DCAQKATOSA-N Ser-Pro-Lys Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CO)N)C(=O)N[C@@H](CCCCN)C(=O)O NMZXJDSKEGFDLJ-DCAQKATOSA-N 0.000 description 2
- XJDMUQCLVSCRSJ-VZFHVOOUSA-N Ser-Thr-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O XJDMUQCLVSCRSJ-VZFHVOOUSA-N 0.000 description 2
- PURRNJBBXDDWLX-ZDLURKLDSA-N Ser-Thr-Gly Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CO)N)O PURRNJBBXDDWLX-ZDLURKLDSA-N 0.000 description 2
- ATEQEHCGZKBEMU-GQGQLFGLSA-N Ser-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CO)N ATEQEHCGZKBEMU-GQGQLFGLSA-N 0.000 description 2
- PQEQXWRVHQAAKS-SRVKXCTJSA-N Ser-Tyr-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)N)CC1=CC=C(O)C=C1 PQEQXWRVHQAAKS-SRVKXCTJSA-N 0.000 description 2
- HSWXBJCBYSWBPT-GUBZILKMSA-N Ser-Val-Val Chemical compound CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)C(O)=O HSWXBJCBYSWBPT-GUBZILKMSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- TZKPNGDGUVREEB-FOHZUACHSA-N Thr-Asn-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O TZKPNGDGUVREEB-FOHZUACHSA-N 0.000 description 2
- JVTHIXKSVYEWNI-JRQIVUDYSA-N Thr-Asn-Tyr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JVTHIXKSVYEWNI-JRQIVUDYSA-N 0.000 description 2
- DCLBXIWHLVEPMQ-JRQIVUDYSA-N Thr-Asp-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 DCLBXIWHLVEPMQ-JRQIVUDYSA-N 0.000 description 2
- WRQLCVIALDUQEQ-UNQGMJICSA-N Thr-Phe-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O WRQLCVIALDUQEQ-UNQGMJICSA-N 0.000 description 2
- STUAPCLEDMKXKL-LKXGYXEUSA-N Thr-Ser-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O STUAPCLEDMKXKL-LKXGYXEUSA-N 0.000 description 2
- NQQMWWVVGIXUOX-SVSWQMSJSA-N Thr-Ser-Ile Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O NQQMWWVVGIXUOX-SVSWQMSJSA-N 0.000 description 2
- AHERARIZBPOMNU-KATARQTJSA-N Thr-Ser-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O AHERARIZBPOMNU-KATARQTJSA-N 0.000 description 2
- AKHDFZHUPGVFEJ-YEPSODPASA-N Thr-Val-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O AKHDFZHUPGVFEJ-YEPSODPASA-N 0.000 description 2
- NBHGNEJMBNQQKZ-UBHSHLNASA-N Trp-Asp-Cys Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)O)N NBHGNEJMBNQQKZ-UBHSHLNASA-N 0.000 description 2
- KLGFILUOTCBNLJ-IHRRRGAJSA-N Tyr-Cys-Arg Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N)O KLGFILUOTCBNLJ-IHRRRGAJSA-N 0.000 description 2
- PMHLLBKTDHQMCY-ULQDDVLXSA-N Tyr-Lys-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O PMHLLBKTDHQMCY-ULQDDVLXSA-N 0.000 description 2
- XJPXTYLVMUZGNW-IHRRRGAJSA-N Tyr-Pro-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O XJPXTYLVMUZGNW-IHRRRGAJSA-N 0.000 description 2
- SQUMHUZLJDUROQ-YDHLFZDLSA-N Tyr-Val-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O SQUMHUZLJDUROQ-YDHLFZDLSA-N 0.000 description 2
- YCMXFKWYJFZFKS-LAEOZQHASA-N Val-Gln-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N YCMXFKWYJFZFKS-LAEOZQHASA-N 0.000 description 2
- OXGVAUFVTOPFFA-XPUUQOCRSA-N Val-Gly-Cys Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)O)N OXGVAUFVTOPFFA-XPUUQOCRSA-N 0.000 description 2
- FEFZWCSXEMVSPO-LSJOCFKGSA-N Val-His-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](C)C(O)=O FEFZWCSXEMVSPO-LSJOCFKGSA-N 0.000 description 2
- ZXYPHBKIZLAQTL-QXEWZRGKSA-N Val-Pro-Asp Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)O)N ZXYPHBKIZLAQTL-QXEWZRGKSA-N 0.000 description 2
- QIVPZSWBBHRNBA-JYJNAYRXSA-N Val-Pro-Phe Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O QIVPZSWBBHRNBA-JYJNAYRXSA-N 0.000 description 2
- JVGDAEKKZKKZFO-RCWTZXSCSA-N Val-Val-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)N)O JVGDAEKKZKKZFO-RCWTZXSCSA-N 0.000 description 2
- 108010044940 alanylglutamine Proteins 0.000 description 2
- 108010087924 alanylproline Proteins 0.000 description 2
- 108010077245 asparaginyl-proline Proteins 0.000 description 2
- 108010047857 aspartylglycine Proteins 0.000 description 2
- 108010068265 aspartyltyrosine Proteins 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 108010060199 cysteinylproline Proteins 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000007071 enzymatic hydrolysis Effects 0.000 description 2
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 2
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 2
- 108010081551 glycylphenylalanine Proteins 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 108010092114 histidylphenylalanine Proteins 0.000 description 2
- 108010044311 leucyl-glycyl-glycine Proteins 0.000 description 2
- 108010047926 leucyl-lysyl-tyrosine Proteins 0.000 description 2
- 108010057821 leucylproline Proteins 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 108010044348 lysyl-glutamyl-aspartic acid Proteins 0.000 description 2
- 108010064235 lysylglycine Proteins 0.000 description 2
- 108010017391 lysylvaline Proteins 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 150000004667 medium chain fatty acids Chemical class 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 108010020432 prolyl-prolylisoleucine Proteins 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 108010033670 threonyl-aspartyl-tyrosine Proteins 0.000 description 2
- 108010061238 threonyl-glycine Proteins 0.000 description 2
- 108010003137 tyrosyltyrosine Proteins 0.000 description 2
- 108010015385 valyl-prolyl-proline Proteins 0.000 description 2
- 108010073969 valyllysine Proteins 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- GNKVBRYFXYWXAB-WDSKDSINSA-N Asn-Glu-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O GNKVBRYFXYWXAB-WDSKDSINSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 102100031375 Endothelial lipase Human genes 0.000 description 1
- RAUDKMVXNOWDLS-WDSKDSINSA-N Glu-Gly-Ser Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O RAUDKMVXNOWDLS-WDSKDSINSA-N 0.000 description 1
- DGKBSGNCMCLDSL-BYULHYEWSA-N Gly-Ile-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)CN DGKBSGNCMCLDSL-BYULHYEWSA-N 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- HGLKOTPFWOMPOB-MEYUZBJRSA-N Leu-Thr-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 HGLKOTPFWOMPOB-MEYUZBJRSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- HGNGAMWHGGANAU-WHOFXGATSA-N Phe-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 HGNGAMWHGGANAU-WHOFXGATSA-N 0.000 description 1
- 101100274274 Secale cereale rsca gene Proteins 0.000 description 1
- DSSOYPJWSWFOLK-CIUDSAMLSA-N Ser-Cys-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(O)=O DSSOYPJWSWFOLK-CIUDSAMLSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 108010025306 histidylleucine Proteins 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 239000003262 industrial enzyme Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Substances OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- LVZSQWIWCANHPF-UHFFFAOYSA-N p-nitrophenyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC1=CC=C([N+]([O-])=O)C=C1 LVZSQWIWCANHPF-UHFFFAOYSA-N 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102220011868 rs386134121 Human genes 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000004230 steam cracking Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
- C12N9/20—Triglyceride splitting, e.g. by means of lipase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/01—Carboxylic ester hydrolases (3.1.1)
- C12Y301/01003—Triacylglycerol lipase (3.1.1.3)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明公开了一种长链不饱和脂肪酸特异性脂肪酶突变体及其应用,属于基因工程技术领域。本发明根据华根霉脂肪酶(RCL)结构分析,对其进行定点突变,获得了脂肪酸特异性改变的突变酶。比较野生型脂肪酶与突变酶催化水解大豆油的能力,得到了水解率远高于野生型脂肪酶的突变酶HQL,水解率达到98%左右。
The invention discloses a long-chain unsaturated fatty acid-specific lipase mutant and an application thereof, belonging to the technical field of genetic engineering. According to the structural analysis of Rhizopus huai lipase (RCL), the invention carries out site-directed mutation to obtain a mutant enzyme with specific fatty acid change. Comparing the ability of wild-type lipase and mutant enzyme to catalyze the hydrolysis of soybean oil, the mutant enzyme HQL whose hydrolysis rate is much higher than that of wild-type lipase is obtained, and the hydrolysis rate reaches about 98%.
Description
Technical Field
The invention relates to a long-chain unsaturated fatty acid specific lipase mutant and application thereof, belonging to the technical field of genetic engineering.
Background
Fatty acid is the most basic in the oil chemical industry and is one of the most widely used raw materials. Hydrolysis of natural oils and fats is one of the important ways to obtain free fatty acids. The production technology of fatty acid mainly comprises saponification, hydrolysis, steam cracking and enzymatic hydrolysis, wherein the enzymatic hydrolysis has the advantages of mild reaction conditions, difficult oxidation of unsaturated fatty acid and few byproducts, and thus becomes a research hotspot of the fatty acid preparation method. Fatty acids of different types, different carbon chain lengths and different proportions have different functions. The short chain fatty acid can be used as feed additive for promoting animal growth. The medium-chain fatty acid is widely applied to the medical, health-care edible oil and breeding industries. Long-chain saturated fatty acids such as palmitic acid and stearic acid are mainly used for producing fatty acid salts as emulsifiers, and are widely contained in animal oils such as pig, cattle and sheep, and the sum of the mass fractions of various saturated fatty acids is usually over 60%. The long chain unsaturated fatty acid has wide physiological activity in metabolism, and can be used for health promotion. The content of unsaturated fatty acid in vegetable oil is high, such as 84.34%, 77.70% and 81.43% in soybean oil, rapeseed oil and camellia oil.
Lipase (EC 3.1.1.3) is a kind of triglyceride hydrolase, which catalyzes hydrolysis or synthesis of ester bond at oil-water interface, and is an important industrial enzyme for processing and manufacturing green oil. Vegetable oil is an important source for preparing long-chain fatty acid, but most lipases have low catalytic efficiency on unsaturated fatty acid or tend to hydrolyze medium-chain fatty acid, so that the raw material utilization rate is reduced when the lipase is applied to hydrolysis of vegetable oil with higher content of long-chain unsaturated fatty acid. For example, Alves et al have shown that the hydrolysis rate of soybean oil catalyzed by single commercial enzymes (Novozym435, Lipozyme TL-IM and Lipozyme RM-IM) is lower than 50%, and that the combination of lipases with different substrate specificities (Lipozyme RM-IM and Novozym435) increases the hydrolysis rate to more than 80% (RSCA advances,2014,4: 6863-. Although the catalytic efficiency of the complex enzyme is remarkably improved, the current research cannot essentially solve the problem of low vegetable oil hydrolysis rate, such as improving the substrate specificity of the enzyme to unsaturated fatty acid, improving the long-chain fatty acid specificity and the like, thereby further improving the vegetable oil hydrolysis rate.
Disclosure of Invention
In order to solve the problems, the invention obtains the mutant enzyme with improved long-chain unsaturated fatty acid specificity by rationally designing the Rhizopus Chinensis (RCL) mutant site, and improves the hydrolysis rate of the soybean oil.
The first object of the present invention is to provide a lipase mutant comprising a change of one, two or three amino acid residues of a substrate binding pocket of a lipase, relative to a lipase having an amino acid sequence shown in SEQ ID NO. 1; the change increases pocket hydrophilicity, which is correlated with lipase specificity for long chain unsaturated fatty acids.
In one embodiment of the present invention, the lipase mutant is a mutant in which glutamine is inserted between histidine 284 of the sequence whose amino acid sequence is shown in SEQ ID NO.1 and leucine 285 of the sequence.
In one embodiment of the invention, the amino acid sequence of the lipase mutant is shown as SEQ ID No. 2.
In one embodiment of the invention, the mutant HQL is obtained by inserting glutamine between histidine at position 284 and leucine at position 285.
The second purpose of the invention is to provide a gene sequence for encoding the lipase mutant.
It is a third object of the invention to provide a plasmid or cell carrying the gene sequence.
In one embodiment of the invention, the cell is a bacterium, a fungus or an archaea.
The fourth purpose of the invention is to provide the application of the lipase mutant in the fields of food, health products and medicines.
In one embodiment of the invention, the application is the hydrolysis of vegetable fat by using the lipase mutant.
In one embodiment of the invention, the application comprises hydrolyzed soybean oil, corn oil, peanut oil, rapeseed oil, olive oil, cottonseed oil, walnut oil.
The invention has the beneficial effects that:
according to the invention, the mutant enzyme with changed fatty acid specificity is obtained by carrying out site-directed mutagenesis on the Rhizopus Chinensis Lipase (RCL) according to the structural analysis of the RCL. Comparing the capability of catalyzing and hydrolyzing soybean oil by wild lipase and mutant enzyme, the mutant enzyme HQL with hydrolysis rate far higher than that of wild lipase is obtained, and the hydrolysis rate reaches about 98%.
Description of the drawings:
FIG. 1 shows the fatty acid chain length specificity of lipases (C2: pNPC2, C4: pNPC4, C5: pNPC5, C8: pNPC8, C12: pNPC12, C14: pNPC14, C16: pNPC 16);
FIG. 2 is a graph showing the hydrolysis characteristics of lipase on saturated and unsaturated fatty acids in soybean oil;
FIG. 3 is a graph of the effect of temperature on lipase activity and stability, where A is the effect of temperature on activity and B is the effect of temperature on stability;
FIG. 4 is a graph of the effect of pH on lipase activity and stability, ApH on activity, B pH on stability;
FIG. 5 shows the lipase-catalyzed soybean oil hydrolysis rate.
Detailed Description
The saponification value of the raw soybean oil is determined by GB/T5534-2008.
Hydrolysis rate (AV)0-AV)/(SV-AV)×100%
In the formula: AV (Audio video)0The acid value of the hydrolyzed sample, mgKOH/g; AV and SV are respectively the acid value and saponification value of the raw material soybean oil, mgKOH/g.
Test method for hydrolyzing soybean oil by lipase: weighing 5g of soybean oil in each sample, adding a certain amount of 50mM potassium phosphate buffer solution into a 50mL triangular flask, and performing ultrasonic treatment to fully emulsify a substrate; the reaction conditions for soybean oil hydrolysis were set to 24 hours, the water-oil mass ratio was 1:1, the enzyme amount was 500U/g (oil weight), pH8.0, temperature was 40 ℃, after the reaction 10mL of 95% ethanol was added to terminate the reaction, and the acid value of the hydrolysate was determined. The method for measuring the acid value is described in GB/T5009.37-2003.
Fatty acid composition analysis: extracting the reacted grease mixture by using n-hexane, separating by Thin Layer Chromatography (TLC) to obtain free fatty acid, putting the free fatty acid into a 10ml colorimetric tube with a plug, adding 1ml of 2% H2SO 4-methanol solution, carrying out water bath at 80 ℃ for 30min, taking out the colorimetric tube, cooling to room temperature, adding 2ml of n-hexane, fully and uniformly mixing, adding a saturated NaCl solution to a bottle mouth, violently shaking, standing for centrifugal layering, collecting an upper n-hexane phase, adding a proper amount of anhydrous sodium sulfate, and carrying out nitrogen-blowing concentration sample injection analysis.
A chromatographic column: DB-Wax (30 m.times.250. mu.m.times.0.25 μm); sample introduction amount: 1 mu L of the solution; the split ratio is as follows: 50: 1; sample inlet temperature: 225 ℃; carrier gas: nitrogen, 30mL min-1; hydrogen, 45mL min-1; air, 450mL min-1; temperature programming: maintaining at 180 deg.C for 1.5min, heating to 210 deg.C at 10 deg.C/min-1, maintaining for 2min, and then heating to 220 deg.C at 5 deg.C/min-1, maintaining for 5 min; a detector: flame Ionization Detector (FID) temperature of 250 ℃. Each sample was tested for 13.5 min.
Calculating the percentage content of the fatty acid component of the soybean oil by adopting an area normalization method on an Agilent GC 6890N gas chromatograph workstation.
The method for determining the hydrolysis activity of the lipase comprises the following steps: the lipase hydrolyzes p-nitrophenol ester to generate p-nitrophenol and fatty acid, the p-nitrophenol shows yellow in aqueous solution and has maximum light absorption at 410nm, and the activity of the lipase can be measured by measuring the light absorption of the p-nitrophenol at 410 nm. The definition of enzyme activity is: the enzyme amount of 1 mu mol p-nitrophenol generated per minute under a certain reaction condition is an international unit of lipase hydrolase activity.
Example 1: site-directed mutagenesis of Rhizopus chinensis lipase
According to the analysis of the crystal structure of the rhizopus chinensis lipase and the comparison of the crystal structures of lipases with similar structures, site-directed mutagenesis and combined mutagenesis are carried out by utilizing the full plasmid PCR technology. Site-directed mutagenesis is carried out by combining a rhizopus chinensis lipase substrate with a pocket at a fixed point.
TABLE 1 primers required for the mutation sites
Factors such as the hydrophilicity and hydrophobicity of amino acids in the binding pocket of the enzyme substrate and the size of the side chain group may affect the substrate specificity of the lipase. Therefore, three mutants were designed from the perspective of increasing the hydrophilicity of the pocket, including L285Q, T286Q and the insertion of a hydrophilic amino acid Q between the sequences H284 and L285, the mutant being designated HQL; three mutation sites were designed from the perspective of increasing steric hindrance, including A116W, I281F, A116W/I281F.
Example 2: fatty acid specificity study of mutant enzymes
The fatty acid chain length specificity of the mutant enzyme of example 1 was examined at pH8.0 and at a temperature of 40 ℃ using p-nitrophenol fatty acid esters of different alkyl carbon chain lengths as substrates (pNPC2, pNPC4, pNPC5, pNPC8, pNPC12, pNPC14, pNPC 16).
As can be seen from fig. 1, the mutant enzyme HQL has enhanced specificity for long-chain fatty acids compared to the wild-type lipase, wherein the specificity for pNPC16 is the highest, and the hydrolysis activity is increased to 2.72 times that of the wild-type lipase. Both mutant enzymes a116W and L285Q had the highest specificity for pNPC16, with 1.23-fold and 1.50-fold hydrolytic activity compared to wild type, respectively. The mutant enzyme I281F widens the range of the length of the hydrolyzed fatty acid chain, increases the hydrolytic activity to the pNPC2, has the highest specificity to the pNPC12, and has the hydrolytic activity 2 times of that of the wild type. In addition, the mutant enzymes L285Q, T286Q, HQL, a116W, a116W/I281F failed to hydrolyze pNPC4, and all of the mutant enzymes had reduced hydrolytic activity against pNPC 8. Through site-directed mutagenesis of a rhizopus chinensis lipase substrate binding pocket, a series of mutant enzymes with changed fatty acid specificity are obtained, and particularly, the mutant enzymes with enhanced specificity to long-chain fatty acids are obtained.
Example 3: research on hydrolysis characteristics of mutant enzyme on fatty acid in soybean oil
In order to examine the substrate specificity of lipase to saturated and unsaturated long-chain fatty acids, measurement was performed using soybean oil rich in such triglycerides as a substrate. The fatty acid composition of soybean oil was first determined to contain 13.77% saturated fatty acids (palmitic acid 11.19%, stearic acid 2.58%), and 86.23% unsaturated fatty acids (oleic acid 25.21%, linoleic acid 54.67%, linolenic acid 6.34%). As can be seen from table 2 and fig. 2, the mutant enzyme HQL enhanced the specificity for unsaturated fatty acids, hydrolyzing unsaturated fatty acids 1.45 times as much as saturated fatty acids, whereas the wild type hydrolyzed unsaturated fatty acids only 1.10 times as much as the saturated fatty acids. The mutant enzyme HQL is more specific to unsaturated fatty acids, and therefore, it is expected that the hydrolysis rate of HQL to soybean oil will be higher than that of the wild-type enzyme. In addition, the mutant enzymes T286Q, I281F and A116W/I281F enhance the specificity to saturated fatty acid, the activity of hydrolyzing the saturated fatty acid is respectively 1.20, 1.83 and 1.34 times of that of unsaturated fatty acid, and the lipase mutants are more suitable for animal fat with high content of saturated fatty acid.
TABLE 2 mutant enzymes catalyze hydrolysis of soybean oil
Example 4: thermostability Studies of mutant enzymes
The activity of the lipase is detected by taking p-nitrophenol palmitate as a substrate (pNPC 16). The lipase activity of the enzyme solution is measured by a standard method at different temperatures (20-60 ℃), the highest enzyme activity is taken as the relative enzyme activity of 100%, and the influence of the temperature on the mutant enzyme activity is researched. And (3) measuring the lipase activity of the enzyme solution after heat preservation is carried out for 1h at different temperatures (20-60 ℃), calculating the residual enzyme activity by taking the enzyme activity without heat preservation as a control, and inspecting the influence of the temperature on the stability of the mutant enzyme.
As can be seen from FIG. 3A, the optimum temperature for all mutant enzyme-catalyzed reactions was 40 ℃ and was consistent with that of the wild type. The activity of the mutant enzyme T286Q can be maintained above 84% at 20-40 deg.C, and other mutant enzymes can retain above 65% at 20 deg.C. However, when the temperature is higher than 40 ℃, the enzyme protein is gradually denatured, the activity of all mutant enzymes is obviously reduced, when the temperature is increased to 60 ℃, the activity of the mutant enzyme HQL is still kept about 20%, and the activity of other mutant enzymes is reduced to below 10%.
FIG. 3B shows the temperature stability of lipase, at 45 deg.C, the activity of HQL and I281F can be maintained at about 80%, only the activity of A116W is reduced to about 50%, and the activity of other mutant enzymes is maintained between 69% -75%. When the temperature exceeds 55 ℃, the activity of the mutant enzyme is rapidly reduced.
Example 5: study of pH stability of mutant enzymes
pH affects the conformation of the enzyme and also affects the dissociation status of the groups involved in catalysis and the dissociation state of the substrate molecules. The activity of the enzyme is affected by the pH of the environment, at a certain pH the enzyme exhibits maximal activity, above or below which the enzyme activity decreases. Respectively preparing 0.05mol/L phosphate buffer solution (pH6.5-pH8), 0.05mol/L Tris-HCl buffer solution (pH8-pH9) and 0.05mol/L carbonate buffer solution (pH9-pH10), respectively adding the enzyme solution into the buffer solutions with different pH values, measuring the lipase activity under the standard condition, taking the highest enzyme activity as the relative enzyme activity of 100%, and researching the influence of the pH value on the mutant enzyme activity. And (3) keeping the temperature of the enzyme solution in the buffer solutions with different pH values for 1h at 25 ℃, measuring the lipase activity of the enzyme solution, calculating the residual enzyme activity by taking the enzyme activity without heat preservation as a control, and inspecting the influence of the pH value on the stability of the mutant enzyme.
As can be seen from FIG. 4A, the optimum pH values of all the mutant enzyme-catalyzed reactions were 8.0, which is consistent with the optimum pH value of the wild type. The pH range is between pH 7.5-9.0, the activity of only mutant enzyme HQLT and I28F can be maintained at above 50%, and the activity of other mutant enzymes is lower than 50% at pH 9.0. Under the conditions that the pH is less than 7.5 and the pH is greater than 9, the enzyme activity is obviously reduced, and the reaction pH obviously influences the activity of the mutant enzyme.
As shown in FIG. 4B, all mutant enzymes were most stable at optimum pH8.0. The mutant enzyme T286Q has poor stability relative to wild type, the enzyme activity can be maintained above 60% at pH 7.5-8.5, and other mutant enzymes can also retain above 50% at pH7.0 and pH 9.0. At pH <7 and pH >9, the stability decreased very rapidly, and only the mutant enzyme I281F maintained 22% activity at pH 10.0.
Example 6: comparison of hydrolytic capacities of soybean oil catalyzed by different mutagens
The reaction conditions for soybean oil hydrolysis were set to 24 hours, the water-oil mass ratio was 1:1, the enzyme amount was 500U/g (oil weight), pH8.0, and the temperature was 40 ℃ to examine the ability of the mutant enzyme to catalyze the hydrolysis of soybean oil. As can be seen from FIG. 5, the mutant enzyme L285Q showed a hydrolysis rate close to that of wild-type catalyzed soybean oil, and the hydrolysis rate was 82%. The mutant enzymes A116W, I281F and A116W/I281F have weaker soybean oil hydrolysis catalyzing ability than wild type enzymes, and the hydrolysis rate is as low as about 70%. The hydrolysis capacity of the mutant enzyme L285Q is slightly higher than that of the wild type, and the hydrolysis rate reaches 88%. The mutant enzyme HQL has the highest capability of catalyzing the hydrolysis of the soybean oil, and reaches about 98 percent. Because the content of unsaturated fatty acid in soybean oil is high and accounts for more than 80%, and the mutant enzyme HQL has stronger specificity to long-chain unsaturated fatty acid than to long-chain saturated fatty acid, the capability of catalyzing and hydrolyzing soybean oil is obviously improved.
Although the present invention has been described with respect to the preferred embodiments, it will be understood by those skilled in the art that various changes and modifications may be made without departing from the spirit and scope of the invention, and it is intended that the scope of the invention be defined by the appended claims.
Sequence listing
<110> university of south of the Yangtze river
<120> long-chain unsaturated fatty acid specific lipase mutant and application thereof
<160>12
<170>PatentIn version 3.3
<210>1
<211>296
<212>PRT
<213> Artificial sequence
<400>1
Asp Thr Glu Thr Val Gly Gly Met Thr Leu Asp Leu Pro Glu Asn Pro
1 5 10 15
Pro Pro Ile Pro Ala Thr Ser Thr Ala Pro Ser Ser Asp Ser Gly Glu
20 25 30
Val Val Thr Ala Thr Ala Ala Gln Ile Lys Glu Leu Thr Asn Tyr Ala
35 40 45
Gly Val Ala Ala Thr Ala Tyr Cys Arg Ser Val Val Pro Gly Thr Lys
50 55 60
Trp Asp Cys Lys Gln Cys Leu Lys Tyr Val Pro Asp Gly Lys Leu Ile
65 70 75 80
Lys Thr Phe Thr Ser Leu Leu Thr Asp Thr Asn Gly Phe Ile Leu Arg
85 90 95
Ser Asp Ala Gln Lys Thr Ile Tyr Val Thr Phe Arg Gly Thr Asn Ser
100 105 110
Phe Arg Ser Ala Ile Thr Asp Met Val Phe Thr Phe Thr Asp Tyr Ser
115 120 125
Pro Val Lys Gly Ala Lys Val His Ala Gly Phe Leu Ser Ser Tyr Asn
130 135 140
Gln Val Val Lys Asp Tyr Phe Pro Val Val Gln Asp Gln Leu Thr Ala
145 150 155 160
Tyr Pro Asp Tyr Lys Val Ile Val Thr Gly His Ser Leu Gly Gly Ala
165 170 175
Gln Ala Leu Leu Ala Gly Met Asp Leu Tyr Gln Arg Glu Lys Arg Leu
180 185 190
Ser Pro Lys Asn Leu Ser Ile Tyr Thr Val Gly Cys Pro Arg Val Gly
195 200 205
Asn Asn Ala Phe Ala Tyr Tyr Val Asp Ser Thr Gly Ile Pro Phe His
210 215 220
Arg Thr Val His Lys Arg Asp Ile Val Pro His Val Pro Pro Gln Ala
225 230 235 240
Phe Gly Tyr Leu His Pro Gly Val Glu Ser Trp Ile Lys Glu Asp Pro
245 250 255
Ala Asp Val Gln Ile Cys Thr Ser Asn Ile Glu Thr Lys Gln Cys Ser
260 265 270
Asn Ser Ile Val Pro Phe Thr Ser Ile Ala Asp His Leu Thr Tyr Phe
275 280 285
Gly Ile Asn Glu Gly Ser Cys Leu
290 295
<210>2
<211>297
<212>PRT
<213> Artificial sequence
<400>2
Asp Thr Glu Thr Val Gly Gly Met Thr Leu Asp Leu Pro Glu Asn Pro
1 5 10 15
Pro Pro Ile Pro Ala Thr Ser Thr Ala Pro Ser Ser Asp Ser Gly Glu
20 25 30
Val Val Thr Ala Thr Ala Ala Gln Ile Lys Glu Leu Thr Asn Tyr Ala
35 40 45
Gly Val Ala Ala Thr Ala Tyr Cys Arg Ser Val Val Pro Gly Thr Lys
50 55 60
Trp Asp Cys Lys Gln Cys Leu Lys Tyr Val Pro Asp Gly Lys Leu Ile
65 70 75 80
Lys Thr Phe Thr Ser Leu Leu Thr Asp Thr Asn Gly Phe Ile Leu Arg
85 90 95
Ser Asp Ala Gln Lys Thr Ile Tyr Val Thr Phe Arg Gly Thr Asn Ser
100 105 110
Phe Arg Ser Ala Ile Thr Asp Met Val Phe Thr Phe Thr Asp Tyr Ser
115 120 125
Pro Val Lys Gly Ala Lys Val His Ala Gly Phe Leu Ser Ser Tyr Asn
130 135 140
Gln Val Val Lys Asp Tyr Phe Pro Val Val Gln Asp Gln Leu Thr Ala
145 150 155 160
Tyr Pro Asp Tyr Lys Val Ile Val Thr Gly His Ser Leu Gly Gly Ala
165 170 175
Gln Ala Leu Leu Ala Gly Met Asp Leu Tyr Gln Arg Glu Lys Arg Leu
180 185 190
Ser Pro Lys Asn Leu Ser Ile Tyr Thr Val Gly Cys Pro Arg Val Gly
195 200 205
Asn Asn Ala Phe Ala Tyr Tyr Val Asp Ser Thr Gly Ile Pro Phe His
210 215 220
Arg Thr Val His Lys Arg Asp Ile Val Pro His Val Pro Pro Gln Ala
225 230 235 240
Phe Gly Tyr Leu His Pro Gly Val Glu Ser Trp Ile Lys Glu Asp Pro
245 250 255
Ala Asp Val Gln Ile Cys Thr Ser Asn Ile Glu Thr Lys Gln Cys Ser
260 265 270
Asn Ser Ile Val Pro Phe Thr Ser Ile Ala Asp His Gln Leu Thr Tyr
275 280 285
Phe Gly Ile Asn Glu Gly Ser Cys Leu
290 295
<210>3
<211>44
<212>DNA
<213> Artificial sequence
<400>3
tttcacctct atcgctgatc accaaaccta ctttggtatt aacg 44
<210>4
<211>44
<212>DNA
<213> Artificial sequence
<400>4
cgttaatacc aaagtaggtt tggtgatcag cgatagaggt gaaa 44
<210>5
<211>49
<212>DNA
<213> Artificial sequence
<400>5
ctttcacctc tatcgctgat cacttacaat actttggtat taacgaagg 49
<210>6
<211>49
<212>DNA
<213> Artificial sequence
<400>6
ccttcgttaa taccaaagta ttgtaagtga tcagcgatag aggtgaaag 49
<210>7
<211>45
<212>DNA
<213> Artificial sequence
<400>7
ttcacctcta tcgctgatca ccaattaacc tactttggta ttaac 45
<210>8
<211>45
<212>DNA
<213> Artificial sequence
<400>8
gttaatacca aagtaggtta attggtgatc agcgatagag gtgaa 45
<210>9
<211>46
<212>DNA
<213> Artificial sequence
<400>9
gtggtactaa ttccttcaga agctggatta ctgacatggt cttcac 46
<210>10
<211>46
<212>DNA
<213> Artificial sequence
<400>10
gtgaagacca tgtcagtaat ccagcttctg aaggaattag taccac 46
<210>11
<211>44
<212>DNA
<213> Artificial sequence
<400>11
actctatcgt tcctttcacc tcttttgctg atcacttaac ctac 44
<210>12
<211>44
<212>DNA
<213> Artificial sequence
<400>12
gtaggttaag tgatcagcaa aagaggtgaa aggaacgata gagt 44
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810097101.3A CN108018273B (en) | 2018-01-31 | 2018-01-31 | Long-chain unsaturated fatty acid specific lipase mutant and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810097101.3A CN108018273B (en) | 2018-01-31 | 2018-01-31 | Long-chain unsaturated fatty acid specific lipase mutant and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108018273A CN108018273A (en) | 2018-05-11 |
CN108018273B true CN108018273B (en) | 2020-05-08 |
Family
ID=62075094
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810097101.3A Active CN108018273B (en) | 2018-01-31 | 2018-01-31 | Long-chain unsaturated fatty acid specific lipase mutant and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108018273B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109750012B (en) * | 2019-03-27 | 2021-10-15 | 云南师范大学 | A lipase mutant and its application |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101899427B (en) * | 2009-11-11 | 2012-05-23 | 江南大学 | Vitality-enhanced lipase mutants constructed by directed evolution |
CN108148823B (en) * | 2012-02-03 | 2023-03-14 | 诺维信公司 | Lipase variants and polynucleotides encoding same |
-
2018
- 2018-01-31 CN CN201810097101.3A patent/CN108018273B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN108018273A (en) | 2018-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Açıkel et al. | Optimization of critical medium components using response surface methodology for lipase production by Rhizopus delemar | |
Kambourova et al. | Purification and properties of thermostable lipase from a thermophilic Bacillus stearothermophilus MC 7 | |
Takó et al. | Purification and properties of extracellular lipases with transesterification activity and 1, 3-regioselectivity from Rhizomucor miehei and Rhizopus oryzae | |
Cao et al. | Purification and characterization of an extracellular lipase from Trichosporon sp. and its application in enrichment of omega-3 polyunsaturated fatty acids | |
Sun et al. | Novel minor lipase from Rhizopus chinensis during solid-state fermentation: Biochemical characterization and its esterification potential for ester synthesis | |
NZ255061A (en) | Fungal strain geotrichum candidum which selectively hydrolyses oleic acid esters over other saturated/unsaturated fatty acid esters, use and cultivation | |
Lima et al. | Mycelium-bound lipase from Penicillium citrinum as biocatalyst for the hydrolysis of vegetable oils | |
Bouaziz et al. | Expression, purification of a novel alkaline Staphylococcus xylosus lipase acting at high temperature | |
JP2023171429A (en) | Novel lipase and use thereof | |
CN108018273B (en) | Long-chain unsaturated fatty acid specific lipase mutant and application thereof | |
Tong et al. | Characterization of a new sn‐1, 3‐regioselective triacylglycerol lipase from Malbranchea cinnamomea | |
Neklyudov et al. | Biochemical processing of fats and oils as a means of obtaining lipid products with improved biological and physicochemical properties: a review | |
US11549130B2 (en) | Random interesterification lipase | |
Choi et al. | Lipase-catalyzed synthesis of 2-ethylhexyl palmitate in a solvent free system using step changes in temperature | |
Robles-Machuca et al. | Comparative features between recombinant lipases CALA-like from U. maydis and CALA from C. antarctica in thermal stability and selectivity | |
CN110982804B (en) | Lipase and application thereof in obtaining DHA (docosahexaenoic acid) glyceride enrichment | |
CN108034647B (en) | A saturated fatty acid specific lipase mutant and its application | |
Lock et al. | Lipases produced by yeasts: powerful biocatalysts for industrial purposes | |
US11685939B2 (en) | Method for producing cis-unsaturated fatty acid by recombinant Candida rugosa lipase 1 (rCRL1) | |
US20140329787A1 (en) | Phytophthora phospholipase c | |
Cai et al. | Substitution and mutation of the C-terminal loop domain of Penicillium expansum lipase significantly changed its regioselectivity and activity | |
Kılıç et al. | Hazelnut seed lipase: extraction, purification, and characterization | |
CN111378643A (en) | Immobilized enzyme composition and its preparation method and use | |
Laachari et al. | Purification and characterization of a Novel Thermostable Lipase from Aspergillus flavus | |
CN114645034B (en) | Enzyme for synthesizing high-purity diglyceride, and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |